Location: Home
  • search
  • go
  • Relate News
  • 6/27/2022Snapshot of Patient Expenditures of Level II and Above Public Hospital...
  • 6/27/2022Amgen Strikes Outliciensing Deal with Fosun for Otezla and Parsabiv in...
  • 6/27/2022Antengene Enters Clinical Partnership with BeiGene to Evaluate Selinex...
  • 6/24/2022At ASCO 2022, Chinese Biotech Firms Deliver Rosy Data On PD-(L)1, Cell...
  • 6/23/2022Sino Biopharmaceutical to Acquire F-Star Therapeutics for $161M
  • 6/23/2022NMPA Announces Package Insert Revision of Glucosamine Formulations
  • 6/23/2022Deloitte Maps Out Four Likely Scenarios for China's Health Ecosystem i...
  • 6/22/2022China's Mental-health Crisis Is Getting Worse (Economist)
  • 6/21/2022China's May Fundraising Indicates Interest in Early-stage Biotech
  • 6/21/2022Xuanzhu Biopharma Out-licenses Greater China Rights of Two Anti-infect...
  • 6/21/2022Innovent and Lilly Jointly Announce Chinese Approval of TYVYT Combo wi...
  • 6/21/2022JPO Issues Bidding Documents for the 7th Round of Volume-Based Procure...
  • 6/21/2022AstraZeneca to Open New Regional Headquarters in Qingdao
  • 6/18/2022Understanding China's Internet Healthcare and Opportunities for Invest...
  • 6/16/2022Pharma Downplays Challenges, Seeing Innovation Instead (Biospace)
  • 6/16/2022May Approvals Spotlight the Rise of Pediatric Drugs under Policy Suppo...
  • 6/16/2022WuXi ATU and Wugen Form Manufacturing Partnership for Novel Cell Cance...
  • 6/15/2022Data Snapshot: Competitive Landscape of Chinese Biosimilars
  • 6/15/2022NMPA Holds Forum to Hear Feedbacks from Pharma MNCs
  • 6/15/2022NHSA Releases the Draft Working Plan and the Application Guide for Adj...
  • 6/14/2022IQVIA: Chinese Retail Pharmacy Sales Down 1.2% in Q1/2022
  • 6/14/2022NHSA Publishes 2021 National Basic Medical Insurance Sector Developmen...
  • 6/14/2022Pharma Giants Turn to Incubators to Tap Chinese Innovation and Hatch S...
  • 6/14/2022FDA's Treatment of China-Developed Drugs Spurs Demands for Multiregion...
  • 6/10/2022Delisting Risk, Souring Relations Are Hurdles for Chinese Biotech Firm...
  • 6/10/2022NHC and SATCM Issue the Rules for Internet Diagnosis and Treatment Reg...
  • 6/9/2022OnCusp and Multitude Enter into an Ex-China Licensing Agreement for a ...
  • 6/7/2022Nicholas Hall Group: Performance of China's Consumer Healthcare Market...
  • 6/7/2022NH's DB6: Top Ten Chinese CHC Brands in 2021
  • 6/7/2022NH's DB6: Chinese OTC Drug Market Forecast 2026/2031
  • Page:42/333 Total number of articles:9989: [First][<<] [40] [41] [42] [43] [44] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group